Morgan Stanley Zai Lab LTD Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Zai Lab LTD stock. As of the latest transaction made, Morgan Stanley holds 3,166,946 shares of ZLAB stock, worth $98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,166,946

Previous 1,714,357 84.73%

Holding current value

$98 Million

Previous $41.4 Million 100.42%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.61 - $33.18 $35.7 Million - $48.2 Million	1,452,589 Added 84.73%	3,166,946 $82.9 Million
Q3 2024 Nov 14, 2024	BUY	$16.25 - $24.14 $19 Million - $28.3 Million	1,170,543 Added 215.25%	1,714,357 $41.4 Million
Q2 2024 Oct 17, 2024	BUY	$13.72 - $21.55 $3.83 Million - $6.01 Million	279,105 Added 105.44%	543,814 $9.42 Million
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $3.83 Million - $6.01 Million	279,105 Added 105.44%	543,814 $9.42 Million
Q1 2024 Oct 17, 2024	SELL	$15.95 - $26.8 $4.45 Million - $7.48 Million	-279,105 Reduced 51.32%	264,709 $4.24 Million
Q1 2024 Aug 16, 2024	SELL	$15.95 - $26.8 $418,320 - $702,883	-26,227 Reduced 9.01%	264,709 $4.24 Million
Q1 2024 May 15, 2024	SELL	$15.95 - $26.8 $418,320 - $702,883	-26,227 Reduced 9.01%	264,709 $4.24 Million
Q4 2023 Aug 16, 2024	SELL	$22.97 - $30.58 $5.81 Million - $7.73 Million	-252,878 Reduced 46.5%	290,936 $7.95 Million
Q4 2023 Feb 13, 2024	BUY	$22.97 - $30.58 $1 Million - $1.33 Million	43,595 Added 17.63%	290,936 $7.95 Million
Q3 2023 Nov 15, 2023	BUY	$22.72 - $31.49 $134,502 - $186,420	5,920 Added 2.45%	247,341 $6.01 Million
Q2 2023 Aug 14, 2023	SELL	$25.3 - $39.67 $2.37 Million - $3.72 Million	-93,790 Reduced 27.98%	241,421 $6.69 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $2.42 Million - $3.86 Million	80,150 Added 31.42%	335,211 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$22.28 - $38.71 $1.48 Million - $2.57 Million	66,489 Added 35.26%	255,061 $7.83 Million
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $1.98 Million - $2.99 Million	-57,844 Reduced 23.47%	188,572 $6.45 Million
Q2 2022 Oct 27, 2022	BUY	$23.14 - $49.68 $2.32 Million - $4.99 Million	100,385 Added 68.74%	246,416 $8.55 Million
Q2 2022 Aug 15, 2022	BUY	$23.14 - $49.68 $2.32 Million - $4.99 Million	100,385 Added 68.74%	246,416 $8.55 Million
Q1 2022 Oct 27, 2022	SELL	$27.77 - $64.4 $2.79 Million - $6.46 Million	-100,385 Reduced 40.74%	146,031 $6.42 Million
Q1 2022 May 13, 2022	SELL	$27.77 - $64.4 $2.28 Million - $5.28 Million	-82,026 Reduced 35.97%	146,031 $6.42 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $3.77 Million - $7.23 Million	68,729 Added 43.14%	228,057 $14.3 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $16.7 Million - $28.4 Million	159,328 New	159,328 $16.8 Million

Others Institutions Holding ZLAB

# of Institutions

145

Shares Held

53M

Call Options Held

103K

Put Options Held

439K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.03B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account